One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2021-146228
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2021 |
Affiliation: Amsterdam University Medical Centers, Presbyterian Hospital, New York Hospital Queens, NewYork–Presbyterian Hospital, Cornell University, University of California, Irvine Medical Center, Vita-Salute San Raffaele University, AstraZeneca (United States), University of Pennsylvania, St James's University Hospital, Jacksonville College, Mayo Clinic, Peter MacCallum Cancer Centre, Royal Melbourne Hospital, The Ohio State University, Dana-Farber Cancer Institute, University of Ulm, AstraZeneca (Japan), The Maria Sklodowska-Curie National Research Institute of OncologyCharacterization of Bruton Tyrosine Kinase Inhibitor (BTKi)-Related Adverse Events in a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia (CLL)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
